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Abstract
Background: Aggregation and cytotoxicity of mutant proteins containing an expanded number of polyglutamine (polyQ)
repeats is a hallmark of several diseases, including Huntington’s disease (HD). Within cells, mutant Huntingtin (mHtt) and
other polyglutamine expansion mutant proteins exist as monomers, soluble oligomers, and insoluble inclusion bodies (IBs).
Determining which of these forms constitute a toxic species has proven difficult. Recent studies support a role for IBs as a
cellular coping mechanism to sequester levels of potentially toxic soluble monomeric and oligomeric species of mHtt.
Methodology/Principal Findings: When fused to a fluorescent reporter (GFP) and expressed in cells, the soluble monomeric
and oligomeric polyglutamine species are visually indistinguishable. Here, we describe two complementary biophysical
fluorescence microscopy techniques to directly detect soluble polyglutamine oligomers (using Htt exon 1 or Htt
ex1) and
monitor their fates in live cells. Photobleaching analyses revealed a significant reduction in the mobilities of mHtt
ex1 variants
consistent with their incorporation into soluble microcomplexes. Similarly, when fused to split-GFP constructs, both
wildtype and mHtt
ex1 formed oligomers, as evidenced by the formation of a fluorescent reporter. Only the mHtt
ex1 split-GFP
oligomers assembled into IBs. Both FRAP and split-GFP approaches confirmed the ability of mHtt
ex1 to bind and incorporate
wildtype Htt into soluble oligomers. We exploited the irreversible binding of split-GFP fragments to forcibly increase levels
of soluble oligomeric mHtt
ex1. A corresponding increase in the rate of IBs formation and the number formed was observed.
Importantly, higher levels of soluble mHtt
ex1 oligomers significantly correlated with increased mutant cytotoxicity,
independent of the presence of IBs.
Conclusions/Significance: Our study describes powerful and sensitive tools for investigating soluble oligomeric forms of
expanded polyglutamine proteins, and their impact on cell viability. Moreover, these methods should be applicable for the
detection of soluble oligomers of a wide variety of aggregation prone proteins.
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Introduction
Numerous cellular proteins are regulated by interconversion
between monomeric and oligomeric states. Distinguishing the
different forms in live cells is challenging and requires the use of
biophysical fluorescence techniques, including Fo ¨rster Resonance
Energy Transfer (FRET) and Fluorescence Correlation Spectros-
copy (FCS) [1,2]or enzymatic reporters that amplify a signal from
weak protein-protein interactions, such as yeast two hybrid or split
luciferase systems [3,4]. While these methods can detect relative
levels of oligomers, the methods do not distinguish the functional
importance of monomeric and oligomeric species, which often co-
exist in cells. For example, if a cytotoxic protein can form soluble
oligomers, is the oligomeric species necessarily cytotoxic? The
problem is especially relevant in Huntington’s disease (HD), other
polyglutamine expansion diseases, and aggregation-prone protein
diseases in general. Knowing whether monomers, soluble
oligomers or both forms are cytotoxic will impact therapeutic
strategies- i.e. which form of the protein to target.
HD is an autosomal dominant neurodegenerative disease
correlated with the expression of a mutant form of the huntingtin
protein (Htt). This ubiquitously expressed large protein contains
3144 amino acids and an uninterrupted series of CAG repeats that
are translated into a polyglutamine (polyQ) tract. Fewer than 36
CAG repeats produces no phenotype. In contrast, individuals with
a copy of mutant Htt (mHtt) containing a pathogenic length of 36
to 150 CAG repeats have HD [5]. The age of pathology onset
correlates inversely with the number of repeats [6]. HD is one of
nine described polyQ diseases. Expression of exon 1 of mHtt is
sufficient to promote development of severe disease symptoms in
mice, resembling the ones observed in HD [7]. Exon 1 includes
the first 67 amino acids of full length Htt with an internal stretch of
a variable number of glutamines. Many HD studies suggest a key
feature distinguishing wildtype (wt) and mHtt N-terminal frag-
ments (including exon 1) is the tendency of the mutant protein to
irreversibly aggregate into SDS-insoluble cytoplasmic amyloid-like
fibrils termed inclusion bodies (IBs) [8,9]. The role of the IBs
remains controversial. While IBs have been associated with
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15245neuronal cell death [10,11,12,13], other studies find cells die
without ever forming IBs and correlate IBs with increased cell
survival [14,15,16,17,18,19]. IBs may act as a cellular coping
mechanism to sequester and detoxify mHtt.
The increased tendency of mHtt to aggregate may represent an
exaggerated behavior of an inherent property of wt Htt. Some
biochemical data suggest wt Htt undergoes physiologic oligomer-
ization in a regulatable manner [20]. For example, homo-
oligomerization of wt Htt fragments can be increased by
overexpression of p21 activated kinase (Pak1) [21]. Other live cell
studies did not detect significant oligomerization of wt Htt
ex1, even
with sensitive biophysical techniques such as FRET [18]. The
functional consequences of oligomerization of wt Htt remain
unclear.
Oligomerization of mutant polyQ proteins appears to be
detrimental to cells [18]. Several studies have employed inhibitory
molecules and antibodies to block polyQ oligomer formation
and observed a corresponding decrease in cell death [22,23,
24,25,26,27,28,29,30,31,32]. Thus, the soluble oligomers forming
prior to IBs may represent the toxic species in HD [33]. Yet, other
studies have raised the potential for the toxicity of conformational
variants of the monomeric species of polyQ proteins [26,34]. The
conformational hypothesis suggests reagents that block oligomer-
ization may also be sterically obscuring toxic protein domains on
monomers [33].
To better define the relevant species for polyglutamine toxicity,
it would be useful to directly monitor both monomeric and
oligomeric species, preferably in intact individual cells that could
also be assayed for susceptibility to death. In addition, a method
for increasing the cellular levels of soluble oligomers could more
directly address the relative toxicities of Htt
ex1 species. It was
demonstrated that various mutant polyQ proteins (including
mHtt
ex1) can form soluble oligomers before IBs appear [18].
FRET approaches have successfully quantified interactions of
mHtt
ex1 in IBs in cells [18,35]. However, detection of FRET
signals for the soluble mHtt
ex1 fraction has yielded conflicting
results [18,35]. FCS performed on lysates of cells expressing
expanded polyQ-GFP also detected formation of soluble oligomers
[30]. Detecting and characterizing the contributions of mutant
polyglutamine monomers and oligomers in cells is fundamental to
the understanding of polyglutamine diseases. Therefore, we sought
to develop new approaches to monitor polyglutamine oligomer
formation in living cells.
Results and Discussion
Experimental design
Two different approaches were employed to quantitate global
changes in the monomeric mHtt pool and detect soluble oligomers
in live cells. To study changes in the total population of mHtt
ex1,
we measured changes in protein mobility, and by extension
molecular size, with Fluorescence Recovery after photobleaching
(FRAP). For FRAP, GFP-tagged proteins are expressed in live cells
and imaged with a scanning confocal microscope. A discrete
region of interest (ROI) in a cell is irreversibly photobleached with
high intensity laser light. Movement of unbleached fluorescent
molecules into the ROI is quantitated over time and analyzed to
determine the diffusion coefficient (D) of the fluorescent molecule
[36]. D (mm
2/s) is inversely proportional to environmental viscosity
and the size of the molecule (hydrodynamic radius or Rh)o ra n
associated molecular complex [37]. Previously, FRAP analysis
revealed that polyQ proteins, when incorporated into IBs, exhibit
exceptionally low mobility [38]. However, these results provide no
indication of the mobility of the polyQ protein prior its
incorporation into IBs. While FRAP can report changes in
molecular size, it provides no information on the composition of
molecular complexes. Decreased mobility of mHtt proteins could
represent mHtt
ex1 oligomers, assemblies with other cellular
proteins, such as chaperones or a mixture of both [39].
To specifically detect Htt oligomers, we employed split-GFP
technology, also termed bimolecular fluorescence complementa-
tion (BiFC). Two non-fluorescent fragments of green fluorescent
protein (GFP) can associate to form a single fluorescent GFP, but
only when they are fused to two proteins capable of interacting
with each other [40,41,42,43]. Split-GFP is sufficiently sensitive to
report weak or transient interactions even for small populations of
interacting proteins that could be otherwise obscured in sensitized
emission FRET experiments [41]. The irreversible nature of the
split-GFP interaction also allows trapping of otherwise transient
interactions [44]. Therefore, this feature can be used to enrich the
pool of oligomeric Htt
ex1in living cells [45]. Using FRAP and split-
GFP, we sought to detect changes in soluble Htt
ex1 oligomer levels
in live cells and correlate oligomer formation with mHtt
ex1
toxicity.
mHtt polyQ expansion and formation of IBs in neuronal
cells
To study mHtt
ex1 aggregation in living cells, Htt
ex1 sequences
containing 23, 73 or 145 CAG repeats were fused to monomeric
GFP (Figs. 1A and B). When transfected into differentiated N2a
cells, Q73 and 145 mHtt
ex1-GFP exhibited diffuse cytoplasmic
fluorescence and gradually developed visible IBs. In contrast, the
wt form, Q23 Htt
ex1-GFP, only exhibited a diffuse cytoplasmic
distribution, similar to previous reports (Fig. 1C and D) [46]. The
Q145 construct developed IBs more quickly and in substantially
more cells than the Q73 construct (Fig. 1D). Interestingly, the
fluorescence intensity of the soluble Q145-GFP measured in cells
not presenting IBs was significantly lower than the Q73 mutant
and the wt Q23 Htt
ex1-GFP at multiple times post-transfection
(Fig. 1E). This difference may reflect an increased propensity of
the Q145 protein to be degraded by the proteasome or other
degradation pathways, such as autophagy [47,48,49]. The
fluorescence result is consistent with the observed comparatively
low levels of Q145-GFP in the whole cell lysate immunoblot
(Fig. 1B).
Potentially pathogenic soluble cytoplasmic forms of Q73 and
Q145 mHtt
ex1-GFP constructs can also be detected using the
3B5H10 antibody, which exclusively stains soluble cytoplasmic
mHtt, but not IBs (Fig. 1F) [34,50]. The 3B5H10 antibody
staining intensity was significantly higher for mutant Q73 and
Q145 constructs relative to the Q23 construct (Fig. 1G) Recently,
this antibody was shown to specifically recognize a potentially
toxic conformation of mHtt monomers [33,34]. Interestingly, even
when cells expressing Q145 Htt
ex1-GFP presented relatively low
cytoplasmic GFP intensity, these same cells exhibited robust
3B5H10 staining, comparable with Q73 expressing cells (Fig. 1G).
The poor correlation between GFP intensity and 3B5H10 staining
likely reflects the affinity of the antibody for extended polygluta-
mine stretches or for a specific conformation of soluble mHtt
constructs.
FRAP analysis reveals the incorporation of mHtt
ex1 into
soluble complexes
To determine whether the various constructs were suitable for
FRAP analysis, we first established whether the GFP-tagged
mHtt
ex1 constructs were mobile in the cytoplasm and, thus,
capable of diffusing. In Fluorescence Loss in Photobleaching
Quantitating Soluble Oligomers in Cells
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ex1-GFP inclusion bodies. (A) Diagram showing the Htt
ex1-
GFP constructs containing 23, 73 and 145 polyQ repeats. (B) Western blot showing the relative sizes of the Q23, 73 and 145 Htt
ex1-GFP constructs
relative to the empty GFP vector. (C) Representative fluorescent images of N2a cells transfected with Q23, 73 or 145 Htt
ex1-GFP for 16 and 48h.
Images were collected with the same settings. (D) Quantitation of the percentage of cells containing IBs for various time points following transfection
with Q23, 73 or 145 Htt
ex1-GFP. (E) Quantitation of the Q23, 73 and 145 Htt
ex1-GFP mean fluorescent intensities at indicated times in cells without IBs.
Each histogram bar is a mean of values for 30 or more cells. (F) Fluorescent images of N2a cells expressing Htt
ex1-GFP constructs containing 23, 73 or
145 polyQ repeats and immunofluorescently labeled with 3B5H10 antibody. (G) Cytoplasmic GFP intensity for individual cells is quantitated and
plotted against the 3B5H10 intensity only in cells not presenting IBs. Images were collected with the same settings Bar=20 mm.
doi:10.1371/journal.pone.0015245.g001
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imaged. All fluorescence within the cell will be depleted if the
fluorescent molecules outside of the ROI are mobile and can pass
through the ROI during the time course of the experiment [36].
FLIP experiments revealed that only the soluble pool of mHtt is
mobile while the IBs appear to be very stable structures (Fig. 2), as
previously described for mHtt and other polyQ proteins
[51,52,53]. Similar mobility results were observed in photoactiva-
tion experiments, in which mHtt
ex1 was fused to photoactivatable
GFP and optically highlighted (Fig. S1).
Next, we used FRAP to determine whether we could detect
quantitative differences in the mobilities of soluble polyglutamine
constructs with increasing numbers of polyQ repeats. No
detectable fluorescence recovery was observed when IBs were
photobleached during the brief time course of the experiment
(data not shown). We predicted all of the soluble Htt
ex1-GFP
constructs would be sufficiently large to diffuse more slowly than
cytoplasmic GFP alone. It was unclear whether the constructs
would diffuse significantly differently from each other. Purified
polyQ rapidly oligomerizes into 180 nm+ diameter aggregates in
Figure 2. Mobility of Htt
ex1-GFP constructs. FLIP analysis of Htt
ex1-GFP mobility in the cytoplasm of N2a cells transfected for 24 h. Repetitive
photobleaching of cells within the cytoplasm, in a small ROI (white outline box), was performed. The 0s image represents the first image after the first
photobleach. The same ROI was photobleached every 5 seconds. By 150 s, nearly all fluorescence had been depleted from all of the cytoplasm,
whereas adjacent cell fluorescence was unaffected. FLIP reveals the presence of small stable IBs (73, arrowhead). When IBs were present, repetitive
photobleaching depleted the cytoplasm fluorescence without significantly affecting the IBs fluorescent intensity (bottom row; arrowhead).
Bar=20 mm.
doi:10.1371/journal.pone.0015245.g002
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mobility in cells [55]. Interestingly, full-length wt Htt with 15
polyQ repeats has a reported large diameter of 19 nm [56].
Soluble mHtt
ex1 oligomers from cells are 4–50 nm in diameter
[57]. Molecules larger than 20–30 nm are not expected to diffuse
significantly within the cytoplasm [58]. In fact, some proteins as
small as 14.4 nm appear effectively immobile in the cytoplasm
[59]. Consistent with FLIP and photoactivation experiments, all of
our Htt
ex1-GFP constructs were mobile in the cytoplasm (Fig. 3A).
However, the Q145 mHtt
ex1-GFP exhibited significantly lower D
values than the Q23 and Q73 Htt
ex1-GFP proteins (Fig. 3B).
Similar results were observed in two additional cell types that were
transiently transfected and analyzed by FRAP (Fig. S2). No
significant correlation between D (mm
2/s) values and the
Figure 3. FRAP analysis reveals incorporation of Htt
ex1-GFP mutants into microcomplexes. (A) Fluorescent images of N2a cells transiently
transfected 16 h (to minimize the number of IBs) with Htt
ex1-GFP constructs containing 23, 73 or 145 polyQ repeats arte shown before (prebleach),
immediately after (t=0) and after recover (t=3.8 s). (B) D values (mm
2/s) of single N2a cells transiently transfected with Htt
ex1-GFP constructs
containing 23, 73 or 145 polyQ repeats and analyzed by FRAP. (C) Plot of D values (mm
2/s) and camera gain settings for N2a cells transiently
expressing Q23, Q73 or Q145 Htt
ex1-GFP. (D) D values (mm
2/s) of single N2a cells transiently cotransfected with Htt
ex1-GFP constructs containing 23,
73 or 145 polyQ repeats and cytosolic mCherry and analyzed by FRAP. (E) D values (mm
2/s) for N2a cells transiently expressing Q23, 73 or 145 Htt
ex1-
GFP for 16, 48 and 72 h. Bar=20 mm.
doi:10.1371/journal.pone.0015245.g003
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ex1-GFP (as measured by microscope
detector gain) was observed (Fig. 3C).
While the sizes of the constructs could account for the mobility
differences, diffusion is also inversely proportional to the
environmental viscosity. Overexpression of Htt-GFP could
potentially alter the cytoplasmic viscosity and confound interpre-
tation of the changes in mHtt
ex1-GFP D (mm
2/s) values. To control
for viscosity changes, we co-transfected N2a cells with the various
Htt
ex1-GFP vectors and an inert cytoplasmic reporter, mCherry.
As in Figure 3B, we detected a reduction in the Q145 mHtt
ex1-
GFP mobility relative to the other constructs. However, no
significant change occurred for the mCherry when co-expressed
with any of the constructs (Fig. 3D). Thus, the observed change in
mobility for Q145 mHtt
ex1-GFP was not due to changes in
cytoplasm viscosity. Therefore, we could calculate apparent size
differences for the different constructs, using the Stokes-Einstein
equation [37]. Assuming GFP has an Rh of 2.3 nm [60], the GFP
fusions to Q23, Q75, and Q145 had Rh values of ,3.15, 3.4, and
3.7 nm, respectively. When factoring in the size of GFP, Q145 is
1.4 fold larger than the Q23 construct based on primary sequence.
With this in mind, the 1.2 fold difference in Rh suggests the
constructs are monomeric or not assembled into larger complexes
at early times post-transfection.
What happens to the sizes of the soluble constructs as cells begin
to accumulate IBs? Previously, FCS analysis of cell lysates
containing pure polyQ-GFP proteins revealed polyQ protein
oligomers form and increase in size up to 8.5 fold over 72 h [30].
Similarly we observed the majority of Q73 and Q145 mHtt
ex1-
GFP protein mobilities decreased in mobility in cells while the
Q23 Htt
ex1-GFP D (mm
2/s) values remain unchanged over 72 h
(Fig. 3E). Thus, pathogenic polyglutamine expansion length
constructs incorporate into mobile soluble complexes, distinct
from IBs.
Detection of Htt
ex1 oligomers using split-GFP in IBs free
cells
Our FRAP results revealed incorporation of mHtt into
increasingly larger complexes of unknown composition. To
determine if at least some of these complexes contain mHtt
oligomers, we turned to split-GFP technology to directly visualize
soluble polyglutamine oligomer formation in living cells
[61,62,63,64,65]. All three (Q23, Q73 and Q145 Htt
ex1) cons-
tructs were fused at their COOH termini to split-GFP variants (1–
157 and 158–238, we termed s157 and s238) [65] of superfolder
GFP (Fig. 4A) [66]. A myc tag was also added to the NH2 terminus
of Htt
ex1 constructs inserted in the 158–258 SFGFP vector. When
expressed separately in N2a cells, split-GFP vectors displayed no
detectable GFP fluorescence (Fig. 4B). The proteins could be
differentially labeled by immunofluorescence to monitor overall
expression levels in the absence of GFP fluorescence (Fig. 4B). Htt
s157-GFP is preferentially recognized by an anti-GFP antibody
[67], while Htt s238-GFP is recognized by the anti-myc antibody
(Fig. 4B). When expressing both pieces of split-GFP fused to the
various Htt
ex1 constructs, all three pairs exhibited GFP fluores-
cence (Fig. 4C). All three constructs displayed GFP signals higher
than the background levels detected for transfection of Q23 Htt
ex1
s238 co-transfected with the negative control cytoplasmic protein,
Nalp1B tagged to s157 (Fig. 4C and D).
GFP fluorescence depended on the position of the split GFP.
Co-transfection of cells with Q73 mHtt
ex1 split-GFP constructs in
which a COOH- terminal S157 Q73 construct was cotransfected
with a Q73 construct with the s238 fused to the NH2 terminus
resulted in no fluorescence (Fig. 4C). Our results are consistent
with the FRET results of Takahashi et al., who reported only
detecting FRET when the fluorescent proteins were placed on the
same end of the two interacting mHtt
ex1 proteins [18]. Thus,
mHtt
ex1 proteins must assemble in parallel to form oligomers.
As we also observed for the intact Q145 mHtt
ex1-GFP fusion,
the split-GFP constructs mean cytoplasmic GFP intensity mea-
sured in cells not presenting IBs was substantially lower than for
Q73 (Fig. 4C and D). This may reflect increased targeting of Q145
for degradation. Remarkably, we detected a robust GFP intensity
for the wt Q23 constructs, demonstrating the wt Htt
ex1 can
oligomerize [21]. We discuss the implications of this observation in
the next section.
When compared to the expression level of the whole intact GFP
construct, Q73 mHtt
ex1 split-GFP fluorescence was significantly
lower, even though the total level of soluble toxic mHtt is similar as
measured with 3B5H10 levels by immunofluorescence (Fig. S3).
These data indicate mHtt
ex1 oligomers represent a minor
population of the total mHtt
ex1 pool. In theory, this is to be
expected. Since 50% of Htt molecules fused to the same split-GFP
moiety could form dimers and the resulting homodimers would be
nonfluorescent, the split-GFP signal should only represent, ideally,
50% of the total pool of Htt oligomers. Furthermore, if the same
total amount of split-GFP constructs relative to intact Q73 GFP is
expressed, then the maximal possible split-GFP fluorescence signal
is only 50% of intact GFP. Together, these two qualifications
should make split-GFP cells only 25% as bright as intact GFP cells,
at best. This assumes all of the split-GFP constructs interact to
form fluorophores.
Next, we compared the mobilities of intact and split GFP Q73
constructs 16h after transfection, in cells without IBs. Q73
mHtt
ex1-split-GFP exhibited a four fold decreased mobility relative
to intact Q73-GFP (mean D6 standard errors of 22.860.7 vs.
6.560.5) (Fig. 4E). This difference is significantly larger than
would be anticipated for simply dimerizing the two proteins. Even
if the molecules were arranged end to end, the predicted increase
in Rh would only be two fold, with a corresponding two-fold
decrease in D. Therefore, the split-GFP Q73 construct oligomer
must contain multiple dimers or associate with cytoplasmic
chaperones. Furthermore, as FRAP is an ensemble measurement,
our results suggest a mean increase in oligomer complex size,
which could easily include the 8.5 fold larger complexes reported
in the FCS study [30].
Incorporation of wt Htt
ex1 into mHtt
ex1 oligomers
Several lines of evidence suggest HD pathology is due to a gain
of function of the mHtt as a result of the extended polyQ stretch
[68]. However, an alternative hypothesis suggests the HD
phenotype is due to loss of function of the wt Htt protein [69].
Consistent with this hypothesis, mHtt
ex1 protein can recruit wt
Htt
ex1 into insoluble aggregates both in vitro and in vivo [70,71,72].
It remains unclear whether wt binds directly to IBs or can
interact with mHtt prior to incorporation into IBs. We investigated
whether wt/mHtt
ex1 soluble oligomers format in living cells. First,
we confirmed our mHtt
ex1 could sequester wtHtt
ex1 into IBs. Q23
Htt
ex1-GFP and Q145 mHtt
ex1-mCherry were co-expressed in
N2a cells. Wt Q23 was readily detectable with Q145 in the IBs
(Fig. 5A). Next, we used FRAP to determine whether coexpression
of wt and mHtt affected diffusion of both proteins (Fig. 5B).
Importantly, we found that expression of Q145 mHtt
ex1
significantly decreased Q23 Htt
ex1-GFP mobility (Fig. 5C). Data
from Figure 3D established oligomer formation does not generally
slow the mobility of other proteins in the cytoplasm. Thus, the
FRAP data in Fig. 5B suggest wt protein incorporates into larger
soluble complexes in the presence of mHtt
ex1. To test whether the
complexes include oligomers of wt and mHtt
ex1, we used the split-
Quantitating Soluble Oligomers in Cells
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between wt and mHtt. The robust fluorescent signal revealed the
ability of mHtt to recruit wt protein into soluble oligomers
(Fig. 5D). These results were subsequently validated with
immunoprecipitations. When coexpressed in N2a cells, Q23
Htt
ex1-GFP was able to pull down Q145 mHtt
ex1-mCherry to a
level similar to cotransfected Q145 Htt
ex1-GFP with Q145
mHtt
ex1-mCherry (Fig. 5E). Experiments were performed at
16 h posttransfection to minimize the number of IBs.
In contrast, little binding was detected between Q23 constructs
fused to intact fluorescent proteins, Q23 Htt
ex1-GFP and Q23
Htt
ex1-mCherry. These data are consistent with a previous report of
low FRET levels between wt Htt fragments [18], but contrast with
our observation of Q23 Htt
ex1 oligomerization when fused to split-
GFP fusion proteins. The split-GFP interaction is irreversible
[44,73]. Therefore, we hypothesize our data reflect accumulation of
otherwise reversible interactions between wt Htt
ex1 monomers.
Unlike interactions of wt Htt
ex1 with mHtt
ex1monomers, wt-wt
Figure 4. Visualization of Htt
ex1-GFP oligomers using split-GFP. (A) Illustration of the fusion of wt and mHtt
ex1 to either 157-GFP or 238-GFP.
(B) Cells transfected with Q23 s157 or Q23 s238 separately, stained with anti-GFP or anti-myc, and imaged for GFP fluorescence intensity (GFP int.). (C)
Representative images of N2a cells transiently transfected with Htt
ex1Q23 157-GFP+Htt
ex1Q23 238-GFP, Htt
ex1Q73 157-GFP+mHtt
ex1Q73 238-GFP,
mHtt
ex1Q145 157-GFP+mHtt
ex1Q145 238-GFP, Nalp1b-157+Htt
ex1Q23 238-GFP or mHtt
ex1Q73 157-GFP+238-GFP mHtt
ex1Q73. (D) Mean fluorescence
intensities in cells without IBs are plotted and compared relative to Q23 means, which were set as 100%. (E) D values of single N2a cells transiently
transfected with mHtt
ex1Q73-GFP or -split GFP constructs and analyzed by FRAP. Bar=20 mm. All fluorescence images were collected with the same
settings.
doi:10.1371/journal.pone.0015245.g004
Quantitating Soluble Oligomers in Cells
PLoS ONE | www.plosone.org 7 December 2010 | Volume 5 | Issue 12 | e15245Htt
ex1 monomer binding events do not result in IBs formation [74].
Thus,split-GFPtechnologyboth detectsandtrapstransientprotein-
protein interactions [44]. Our data reveal mHtt can and does
sequester wt protein regardless of whether IBs form. Interestingly,
an increased number of polyQ repeats in mHtt N-terminal
fragments prevents wt fragments binding to Hip-1, leaving the
latter free to form pro-apoptotic complexes [75]. Formation of wt
and mHtt hetero-oligomers may contribute to this phenomenon.
We speculate these previously difficult to detect interactions in cells
are likely to be important to pathogenesis of polyglutamine diseases.
Figure 5. Incorporation of wt Htt
ex1-GFP into mutant oligomers. (A) Representative fluorescent images of N2a cells cotransfected with
Htt
ex1Q23-GFP and Q145-mcherry for 48 h. (B) Fluorescent images of N2a cells transiently cotransfected with Htt
ex1Q23-GFP and mHtt
ex1Q145-
mCherry constructs are shown before (prebleach), immediately after (t=0) and after recover (t=6s). (C) D values for N2a cells co-expressing
Htt
ex1Q23-GFP+mCherry, Htt
ex1Q23-GFP+mHtt
ex1Q145-GFP plus cytoplasmic mCherry, and mHtt
ex1Q145-GFP+cytoplasmic mCherry and
mHtt
ex1Q145-GFP+Htt
ex1Q23-mCherry. (D) Representative fluorescent images of N2a cells transiently transfected Htt
ex1Q23 s157-GFP+Htt
ex1Q23
s238-GFP, mHtt
ex1Q145 s157-GFP+Htt
ex1Q23 s238-GFP. All images were collected with the same settings for each channel. (E) N2a cells cotransfected
with Htt
ex1Q23-GFP+cytoplasmic mCherry, Htt
ex1Q23-GFP+Htt
ex1Q23-mCherry, Htt
ex1Q23-GFP+mHtt
ex1Q145-mCherry or mHtt
ex1Q145-
GFP+mHtt
ex1Q145-mCherry. Lysates were incubated with anti-GFP-agarose beads and the lysates and coimmunoprecipitation are shown on
immunoblots probed with anti-GFP and anti-mCherry. Bar=20 mm.
doi:10.1371/journal.pone.0015245.g005
Quantitating Soluble Oligomers in Cells
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In light of our findings, we asked if increased mHtt
ex1
oligomerization affected IBs formation and mHtt
ex1 toxicity. In
their FRET study, Takashi and colleagues reported the soluble
form of mHtt
ex1 represents the toxic species in HD [18] and IBs
are protective [14]. However, they did not observe a significant
correlation between mHtt
ex1 oligomer formation (FRET positive)
and cell death when compared to FRET negative cells. The result
suggests both mHtt oligomers and b-strand polyQ monomers are
potentially toxic to cells. In addition, the conformation of mHtt
ex1
may be a determinant of its toxicity [76].
To test whether or not incorporation of mHtt into potentially
oligomeric complexes impacts cell viability, we used our FRAP
assay to determine if mHtt mobility correlates with neuronal cell
survival. N2a cells were transfected with the live cell apoptosis
reporter ER-DEVD [77]. The reporter localizes to the endoplas-
mic reticulum (ER). Upon induction of apoptosis with staurospor-
ine, activated caspases cleave the DEVD peptide in the reporter,
releasing it from the ER membrane, followed by translocation to
the nucleus (Fig. S4). N2a cells were cotransfected with ER-
DEVD-tdTomato and then Q145 mHtt
ex1-GFP and analyzed by
FRAP 48 h posttransfection. FRAP was performed on cells
without (no caspase activity) and with nuclear localized reporter
(+caspase activity) and Q145 mHtt
ex1-GFP mobility was calculat-
ed. Consistent with the mHtt FRET reporter results, no
relationship was observed between mHtt mobility and cell death
(Fig. 6A) [18]. The FRAP results do not resolve the relative
contributions of monomeric and oligomeric mHtt
ex1, each of
which may be equally toxic.
To investigate the cellular consequences of increased levels of
mHtt
ex1 oligomers, we exploited the irreversible nature of the split-
GFP complementation system. We hypothesized the split GFP
would increase the concentration of oligomers in two ways. First,
the irreversibility of split-GFP makes it a powerful trap for
normally transient interactions [44]. Second, the nonproductive
dimers formed by constructs containing the same split-GFP
fragment will not be trapped and, should, associate at some rate
with a complementary split-GFP fragment to be trapped. Thus,
split-GFP should increase the fraction of detectable (by GFP
fluorescence) and irreversible dimers of mHtt
ex1. Indeed, when run
on a native polyacrylamide gel, Q23 Htt
ex1 fused to split-GFP
constructs exhibited formation of higher molecular weight
complexes when compared to the Htt
ex1 fused to intact GFP
migrated much more rapidly as a small, presumably monomeric
species (Fig. S5). Interestingly, Q23-s157 was unable to induce the
formation of higher oligomers when expressed with Q23 fused to
intact GFP (Fig S5). This result confirmed the ability of split-GFP
to stabilize otherwise transient interactions. Based on these data,
we then asked if trapping mHtt
ex1-mHtt
ex1 interactions would
increase IBs formation. Fusion of mHtt
ex1 to split-GFP enhanced
both the rate of IBs formation and the number of cells with IBs,
relative to mHtt fusions to intact GFP (Fig. 6B). Our data do not
exclude the possibility that monomeric mHtt
ex1 may also be
recruited to IBs [33].
Next, we asked whether increased levels of soluble mHtt
oligomers enhance cytotoxicity of polyglutamine proteins. Follow-
ing transfection, levels of plasmid expressed proteins should
steadily increase. Higher protein concentrations should increase
the probability of protein oligomerization and aggregation. Cells
expressing mHtt
ex1 fused to intact GFP exhibited increasing levels
of caspase activity with increasing time post-transfection (Fig. 6C).
No caspase activity was observed for cells expressing Q23-GFP
(Fig. 6C). When Htt-GFP expressing cells were categorized as
having or lacking IBs, a significant trend was revealed. Consistent
with previous reports, cells had reduced apoptotic activity when
IBs were present compared to cells with diffuse cytoplasmic mHtt,
[14,18] (Fig. 6C). The percent of cells with caspase activity
remained low over 48h for Q73-GFP expressing cells containing
IBs, but increased about 50% for cells expressing Q145-GFP
(Fig. 6D). These data suggest the presence of IBs could help
protect cells from mHtt cytotoxicity and are consistent with
previous reports [14,18]. As with the FRAP data, it remained
unclear whether soluble monomers or oligomers preferentially
affected mHtt-GFP cytotoxicity.
With the split-GFP constructs, two trends immediately stand
out. First, mHtt split-GFP expressing cells have substantially
higher levels of caspase activity and this occurs in a much higher
percentage of cells compared to cells expressing intact GFP
constructs (Figs. 6C and D). Interestingly, the dramatically
increased caspase activity was observed earlier than for cells
expressing intact GFP constructs (Fig. 6C). Second, fusion of
mHtt
ex1 to split-GFP significantly increased the average caspase
activity per cell regardless of the presence of IBs compared to cells
expressing intact GFP fusions to mHtt
ex1 (Figs. 6C and D). Soluble
mutant polyglutamine expression levels of both the intact or split-
GFP correlated with increased caspase activity (Fig. 7). Impor-
tantly, higher levels of soluble oligomers strongly correlate with
increased cytotoxicity (Fig. 7). Caspase activity typically only
occurred above some threshold level of any of the mHtt
ex1
constructs (Fig. 7). That is, mHtt
ex1 must achieve a critical
concentration in cells to induce caspase activation. Taken
together, our results strongly implicate soluble polyglutamine
oligomers as an important (if not the predominant) toxic species in
polyglutamine disease pathogenesis.
The intact and split-GFP construct results indicate IBs are
neither required for toxicity nor do IBs appear to enhance
polyglutamine toxicity. Notably, a high percentage of cells
expressing mHtt
ex1 split-GFP contained IBs and exhibited caspase
activity (Fig. 6D). This contrasts with the report of Arrasate et al.
[14,18] describing how the presence of IBs formed from intact
GFP mHtt
ex1 constructs correlated with enhanced cell survival.
Could split-GFP, itself, cause cytotoxicity? We observe Q23
split-GFP also forms oligomers, but with no apparent cellular
toxicity (Figs. 4C, D, and 6C). Split-GFP alone caused no apparent
toxicity. As the only differences between Q23 and the Q73 and
Q145 constructs are the numbers of polyglutamine repeats, we
suggest cytotoxicity is due to oligomerization of extended
polyglutamine proteins. Also, the use of split-GFP does not alter
the trend of Htt
ex1 toxicity, since mHtt
ex1 fragments tagged to
regular GFP are also toxic. However, increased mHtt
ex1
oligomerization due to split-GFP does, in fact, result in an increase
in the absolute toxicity of mHtt
ex1 intermediate oligomers.
It is possible the split-GFP IBs could represent a novel cytotoxic
species or could lack cytoprotective properties of intact GFP IBs.
We consider it more likely that the rates of oligomer formation and
IBs formation represent the relevant parameters for predicting cell
survival outcomes. While we observed higher numbers of cells with
split-GFP IBs and the rate of IBs formation was faster (Fig. 6B),
mean caspase activity was not significantly higher than in cells with
soluble cytoplasmic split-GFP extended polyglutamine constructs
(Fig. 6C). This would suggest IBs could form at the time of or even
after caspase activation. Furthermore, the constitutive production
of split-GFP polyglutamine constructs with a high tendency to
oligomerize could substantially increase the rate of soluble
polyglutamine oligomer formation regardless of the presence of
IBs, possibly overwhelming oligomer sequestration by the IBs
formation pathway.
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regulated process. Relatively small oligomers or aggregates are
specifically trafficked by the motor dynein along microtubules to
the perinuclear microtubule organizing center [78]. There,
cellular proteins, including p62, stimulate autophagic degradation
of IBs [78]. We hypothesize that either sequestration of oligomers
into IBs or the rate of autophagic clearance may not be sufficiently
accelerated in the split-GFP system to cope with higher soluble
oligomer levels. The split-GFP system now provides a powerful
tool for investigating the kinetics and responsiveness of the IBs-
autophagosome pathway to exceptionally high levels of soluble
oligomers.
Conclusions
Using two different and complementary approaches, we have
followed changes in the oligomeric state of soluble mHtt
ex1 in cells.
Figure 6. Fusion of mHtt to split-GFP results in increased IBs formation and cell death. (A) D values (mm
2/s) for N2a cells transiently
cotransfected with mHtt
ex1Q145-GFP and ER-DEVD-tdTomato. (B) Quantitation of percentage of cells containing IBs for indicated times
posttransfection with Htt
ex1Q23, 73 or 145 fused to SFGFP or split-SFGFP constructs. n.215 cells. * p,0.05, ** p,0.005 compared to same length of
polyQ fused to GFP. (C) N2a cells were cotransfected with Htt
ex1-GFP or Htt
ex1 split-GFP and ER-DEVD-tdTomato. Both aggregation and cell death
were monitored at 24 and 48h posttransfection in cells without (-) or with IBs (inclusion bodies). Each histogram bar reports the mean caspase activity
6 standard error. n.38 cells per condition. * p,0.05, ** p,0.005 compared to same parameter (+ or 2 IBs) for the same Htt
ex1 construct fused to
GFP unless specified. (D) Table of percentages of cells with caspase activity with or without IBs.
doi:10.1371/journal.pone.0015245.g006
Quantitating Soluble Oligomers in Cells
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polyglutamine expansions to incorporate into progressively larger
soluble complexes. These complexes are likely to include
chaperones and potentially other proteins [75,79,80]. However,
FRAP does not report whether complexes contain more than one
mHtt
ex1 molecule or even the general composition of complexes.
Our FRAP results are consistent with the native gel results of
Legleiter et al. [33] and Takahashi et al. [30], who observed
greater than 50% of pathogenic polyQ constructs incorporate into
complexes significantly larger than a nonpathogenic construct.
Split-GFP constructs revealed the capacity of all of the constructs
to form oligomers of at least two mHtt
ex1 molecules. However, the
trapping ability of split-GFP prevents us from quantitating the
fraction of dimer or higher oligomers that normally would exist at
steady state. A recent study by Takahashi et al [30] reported detecting
soluble complexes containing at least 3.5 monomers. Similarly,
Ossato et al [81] measured oligomers of 5–15 mHtt
ex1 molecules in
cells, using a ‘‘number and brightness method.’’ Soluble oligomers
never constituted more than 20% of the total soluble mHtt
ex1 in the
Ossato et al. study. However, our data suggest the majority ($50%) of
mHtt
ex1-GFP reporters must be incorporated into complexes of
significantly increased size to cause the observed decrease in D for
FRAP and the slowed migration in native gels. This is because native
gels and FRAP experiments are ensemble measurements, which
detect relatively large changes for the entire population of proteins.
Previously,increasinglevelsofsoluble polyglutamineoligomersin
cells has required either expressing higher levels of polyglutamine
proteins or regulating a co-factor of polyglutamine oligomerization.
For example, Luo et al. stimulated oligomerization of mHtt
fragments by overexpression of Pak1 [21]. Increased IBs formation
and cell death followed, though the assay used did not directly
investigate cell fates relative to the presence or absence of IBs. Split-
GFP trapping of polyglutamine oligomers enabled us, for the first
time, to directly demonstrate the higher propensity of soluble
polyglutamine oligomers to form IBs and the increased toxicity of
soluble oligomers in living cells without manipulating other cellular
parameters. However, by artificially trapping monomer interactions
and accelerating IBs formation, the split-GFP method increases the
normal rate of conversion of monomers into oligomers and the flux
of oligomer integration into IBs.Thus, the split-GFP method under-
emphasizes any potential role monomer levels play in cell fate.
While we cannot exclude the potential toxicity of mHtt
ex1
monomers, our data establish that driving oligomerization clearly
enhances the cytotoxic potential of mHtt
ex1.
Taken together, an emerging picture of mHtt oligomerization in
cells suggests all Htt
ex1 constructs, including the nonpathogenic
Q23, can form transient oligomers. Pathogenic polyQ constructs
progressively incorporate into large complexes in cells, some of
which include additional copies of polyQ constructs. Formation of
complexes containing two or more copies of pathogenic polyQ
molecules substantially impairs cell viability. Future studies will
need to tease apart the relative toxicities of different soluble
oligomers, i.e. do increasingly larger numbers of polyQ molecules
in complexes increase cytotoxicities.
Figure 7. Levels of soluble cytoplasmic mHtt
ex1 are a negative predictor of cell death. N2a cells were cotransfected with Q23, 73 or 145
Htt
ex1 fused to GFP or split-GFP and ER-DEVD tdTomato for 48 h. GFP or split-GFP intensities and the nuclear/ER ratio of the apoptosis reporter were
quantified for individual cells not presenting IBs. In each plot, the cell with the brightest GFP intensity was defined as having a mean intensity of 100
arbitrary units and other cell intensities were converted to this scale. Thus intensities in one plot are not directly comparable to intensities in another
plot. Each square represents a single cell. Increasing mHtt
ex1, but not wt Htt
ex1, levels above some threshold were associated with increased cell
death. The existence of apparent thresholds correlating with activation of the caspase activity suggests mHtt
ex1 toxicity is sharply concentration
dependent and may depend on titration of one or more key cellular factors.
doi:10.1371/journal.pone.0015245.g007
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PLoS ONE | www.plosone.org 11 December 2010 | Volume 5 | Issue 12 | e15245Our findings support the hypothesis that mHtt oligomers are
indeed the toxic species in HD. Given the increasing body of
evidence against a pathogenic role for IBs in polyglutamine
diseases, we suggest therapeutics that block formation of soluble
polyglutamine oligomers merit investigation. The split-GFP
methodology is well suited for a noninvasive high throughput
screen to identify compounds capable of inhibiting polyglutamine
oligomerization in cells.
Materials and Methods
Cell lines
Neuro-2a (N2a), U-2 OS, and HEK 293t cells were obtained
from ATCC. Cells were grown in 8-well Lab-tek chambers
(Nunc; Rochester, NY) in RPMI media (Mediatech; Manassas,
VA) containing 10% fetal bovine serum (Hyclone from Thermo
Scientific; Rockford, IL), glutamine and penicillin/streptomycin
(Invitrogen; Carlsbad, CA), in a 5% CO
2 incubator at 37uC. N2a
cells were routinely differentiated by incubating the cells with
5mM dbcAMP (N69,2 9-O-dibutyrilaenosine-39:59-cyclic mono-
phosphate sodium salt) (Sigma-Aldrich; St. Louis, MO) for two
days.
Constructs and transfection
Htt
ex1Q23, Q73 and Q145 constructs were obtained from the
Coriell Institute for Medical Research and the CHDI Foundation.
Htt
ex1 fragments were amplified by PCR using the following
primers:
forward primer GATCAGATCTGCCACCATGGCGACC-
CTGGAAAAG
reverse primer GATCACCGGTCCTGGTCGGTGCAGC-
GG
and subcloned into the BglII and Age1 site of monomeric
pEGFP-N1 vector.
Split-GFP constructs were generated by PCR using pEGFP-N1
as a template with the following primers:
Split-GFP 1–157 was amplified using the
forward primer GCAAATGGGCGGTAGGCG
reverse primer GATCGCGGCCGCTTACTGCTTGTCGG-
CCATG
and subcloned into Age1 and Not1 of SFpEGFP-N1. Split-GFP
158–238 was amplified using the
forward primer GATCACCGGTCCGGGAGCAAGAACGG-
CATCAAG
reverse primer GGTTCAGGGGGAGGTGT
and subcloned into Age1 and Not1 of pSuperfolderGFP-N1
[66].
The ER DEVD tdTomato vector was generated by PCR
amplification of tdTomato [82] using the following primers:
forward primer GATCACCGGTATGGTGAGCAAGGGC
reverse primer GGTTCAGGGGGAGGTGT
and subcloned the resulting fragment into ER-DEVD-mStraw-
berry [77] using the Age1 and BsrG1 sites.
The Nalp1b allele 2 split-GFP was generated by PCR by
amplifying Nalp1b using the
forward primer GATCGCTAGCGCCACCATGGAACAA-
TCTCAG
reverse primer GATCCCCGGGCACCGGTACGCGTAGA
The resulting fragment was cloned into split-GFP-N1 vectors
using the Nhe1 and Xma1 sites.
DNA constructs were transfected into N2a cells using
Lipofectamine 2000 transfection reagent (Invitrogen) according
to manufacturer instructions.
Aggregation assay and quantification
N2a cells were plated and differentiated for two days prior
transfection with Htt
ex1-GFP or split-GFP constructs. Cells were
imaged at various time points following transfection. Imaged were
collected using fluorescence microscopy with a widefield micro-
scope, Axiovert 200, (Carl Zeiss Microimaging Inc., Thornwood,
NY) 636 oil NA 1.4 objective, 450–490 excitation/500–550
emission bandpass filter) and a Retiga 2000R camera (QImaging;
Surrey, BC). The percentage of cells containing at least one or
more IBs was quantified.
FRAP and FLIP
Cells were imaged in phenol red–free RPMI supplemented with
10mM HEPES and 10% FBS. Live cells were imaged on a 37uC
environmentally controlled chamber of a Duoscan confocal
microscope system (Carl Zeiss Microimaging) with a 636 NA
1.4 oil objective and a 489 nm 100 mW diode laser with a 500–
550 nm bandpass filter for GFP. FRAP and FLIP experiments
were performed by photobleaching a region of interest at full laser
power of the 489 nm line and monitoring fluorescence loss or
recovery over time. No photobleaching of the adjacent cells during
the processes was observed. Diffusion coefficient (D) measurements
were calculated as described previously [36,83].
Photoactivation
N2a cells were transfected with Htt
ex1-PA-GFP constructs for
24h and image on confocal microscope as previously described.
Photoactivation experiments were performed by bleaching a small
ROI within the cells with a 405 nm laser while constantly imaging
cells with a 489 nm laser to detect activated state of PA-GFP.
Quantitative fluorescence microscopy
Cells were fixed with freshly diluted 3.7% formaldehyde in PBS
for 15 min at RT, permeabilized with PBS with 0.1% Triton X-
100. Blocking was performed in 10% fetal bovine serum in 16
PBS. Subsequently, cells were labeled with anti-monomeric
polyglutamine antibody 3B5H10 (Sigma Aldrich), followed by
Alexa 555-conjugated anti-rabbit IgG secondary antibodies. Cells
were imaged using fluorescence microscopy with an Axiovert 200
widefield microscope (Carl Zeiss Microimaging Inc.) with a 636
oil NA 1.4 objective, 450–490 excitation/500–550 emission
bandpass filter. Image analysis was performed with ImageJ
(National Institutes of Health; Bethesda, MD).
An important technical note is that the high fluorescence
intensity of IBs saturates the CCD detector in the GFP channel,
obscures the fluorescent signal of soluble GFP construct levels, and
thus limits our ability to quantitate soluble GFP construct levels in
IBs containing cells. Therefore, most of our study focuses on cells
prior to the appearance of IBs. Alternatively, cells containing IBs
are scored in general terms of having or not having IBs, without
any attempt to quantitate absolute GFP intensity levels in those
cells.
Cell death
Cells were cotransfected with Htt
ex1-GFP and ER-DEVD-
tdTomato constructs. Alternatively, cells were transfected with
ER-DEVD-tdTomato and treated for 3 h with 5 mM staurospor-
ine (EMD Biosciences; Gibbstown, NJ). Fluorescent images were
acquired with a widefield fluorescent microscope as previously
described. For the ER DEVD-tdTomato, fluorescent intensity
within the nucleus and the ER were obtained with ImageJ.
Caspase activity was calculated by obtaining the ratio of mean
fluorescence intensity of the nucleus divided by the intensity of the
Quantitating Soluble Oligomers in Cells
PLoS ONE | www.plosone.org 12 December 2010 | Volume 5 | Issue 12 | e15245ER. Increase in caspase activity in mHtt expressing cells was
quantified by calculating the % of cells with Nucleus/ER ratio
higher than the average value obtained for Q23 Htt
ex1-GFP.
SDS-PAGE and immunoblot
N2a cells were plated in 12 well plates, differentiated and
transfected with either Htt
ex1 constructs fused to GFP or split-
GFP. Cells were rinse twice with PBS and cells were lysed in 50 ml
of sample buffer containing 1% SDS, 0.1 M Tris, pH8.0. Lysate
were run on 12% Tris-tricine gels and transferred to nitrocellulose
membrane, Antibodies used included anti-GFP and anti-RFP
(generous gifts from Ramanujan S. Hegde), and HRP-labelled
anti-rabbit (Jackson Immunoresearch Laboratories).
Immunoprecipitations
For immunoprecipitations, N2a cells expressing Htt
ex1 con-
structs in 6-well plates were washed twice with 16PBS and lysed
with IP buffer (1% Triton X-100, 50mM Hepes, pH 7.4, 100mM
NaCl) containing EDTA-free protease inhibitor cocktail (Roche).
Lysates were clarified for 10 min at maximum speed in a
microcentrifuge at 4uC and incubated for 2 h at 4uC with agarose
conjugated anti-GFP beads (MBL ltd.). The beads were washed
four times in IP buffer, once in distilled water, eluted with SDS-
PAGE sample buffer, and analyzed on 12% Tris-glycine gels,
followed by blotting, staining, and development as for immuno-
blots.
Native gel
N2a cells were plated in 12 well plates, differentiated and
transfected with either Htt
ex1 constructs fused to GFP or split-
GFP. Cells were rinsed twice with native buffer (20mM Hepes,
150 mM NaCl and protease inhibitor cocktail). Then cells were
lysed in cold native buffer containing 0.2% triton X-100. Sample
were clarified by centrifugation and loaded on a 7.5% Tris-glycine
native gel. Tris-glycine buffer was used as running buffer and gels
were allowed to migrate for 4 h. Proteins were subsequently
transferred on nitrocellulose membrane and processed for
immunoblot for anti-GFP.
Supporting Information
Figure S1 The mobility of Htt
ex1 revealed by GFP photoacti-
vation. N2a cells were transfected with Q23, 73 or 145 Htt
ex1-PA-
GFP for 24 h. Photoactivation a small ROI within the cytoplasm
was performed with a 405 nm laser. By 5 s postactivation, the
photoactivated pool of Htt
ex1-PA-GFP has diffused throughout the
entire cytoplasm. When IBs (bottom Q145 panels) were
photoactivated, no significant redistribution of the mHtt
ex1-PA-
GFP to the rest of the cytoplasm was observed.
(TIF)
Figure S2 D values (mm
2/s) of single cells transiently transfected
with Htt
ex1-GFP constructs containing 23, 73 or 145 polyQ
repeats for 16 h and analyzed by FRAP in 293 and U-2 OS cells. *
p,0.05 compared to Q23 Htt
ex1-GFP.
(TIF)
Figure S3 (A) Comparison of Htt
ex1-GFP and split-GFP
fluorescence intensities. N2a cells were transfected for 24 h with
Q73 mHtt
ex1-GFP or split-GFP, fixed and immunofluorescently
labeled with 3B5H10 antibody. Both constructs were imaged using
the same exposure time for both channels. Subsequently exposure
time was increased for split-GFP to reveal the GFP signal.
Bar=20 mm. (B) Plot of D values and camera gain settings for
N2a cells transiently expressing Q73 Htt
ex1-GFP or Q73 Htt
ex1-
Split-GFP. Note that lower gain settings are used for brighter cells.
(TIF)
Figure S4 Validation of the ER-DEVD-tdTomato reporter
functionality. N2a cells were transfected with ER-DEVD-tdTo-
mato for 16 h and then treated with or without 5 mM
staurosporine for 3h. The fluorescent intensity ratio of the nucleus
over the ER calculated is presented in the plot. ** p,0.0001
compared to untreated cells. Bar=20 mm.
(TIF)
Figure S5 Comparison of Htt
ex1 –GFP and Split-GFP con-
structs migration on native gel. Lysates from N2a cells cotrans-
fected with Q23, 73 or 145 Htt
ex1 fused to GFP or split-GFP were
run onto a native gel and process for immunoblot with anti-GFP.
Htt
ex1 split-GFP constructs forms higher molecular weigh
complexes than those fused to intact GFP. Interestingly, when
Q23s157 is coexpressed with Q23-GFP, interaction is not possible
and this is reflected by its inability to form higher complexes
observed when expressed with the Q23 s238.
(TIF)
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